You are here

RoActemra

Roche’s Actemra/RoActemra approved for treatment of severe COVID-19 in the EU

Biopharma Reporter

Tue, 12/7/21 - 11:04 am

Further Studies Show Conflicting Results of Arthritis Drug for Severe COVID-19

BioSpace

Fri, 01/22/21 - 10:35 am

Roche’s tocilizumab fails to achieve primary endpoints for Covid-19-related pneumonia

Pharmaceutical Business Review

Thu, 07/30/20 - 10:59 am

clinical trials

COVID-19 pneumonia

Roche and Gilead Launch COVID-19 Trial to Test One-Two Punch of Actemra and Remdesivir

BioSpace

Thu, 05/28/20 - 10:59 pm

Gilead Sciences

clinical trials

COVID-19 pneumonia

Roche's RoACTEMRA To Go Up Against Anti-Rheumatoid Arthritis Drugs From Bristol-Myers, AbbVie

Bidness Etc.

Mon, 09/8/14 - 12:29 pm

rheumatoid arthritis

Bristol-Myers Squibb

Roche says arthritis drug beats top-selling rival in trial

Reuters

Wed, 06/6/12 - 10:45 am

rheumatoid arthritis

Abbott Laboratories

Roche Should Give More Data on RoActemra Drug, U.K.’s NICE Says

Bloomberg

Wed, 12/16/09 - 10:10 am

rheumatoid arthritis